Verona Pharma plc (VRNA) Tops Q2 EPS by 2c

Verona Pharma plc (NASDAQ: VRNA) reported Q2 EPS of ($0.01), $0.02 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Verona Pharma plc (VRNA) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Vislink Technologies Inc. (VISL) Misses Q2 EPS by 7c
• Laser Photonics Corporation (LASE) Reports Q2 Loss of $0.08